Melanoma Diagnosis Linked to Increased Risk of Prostate Cancer
A more than 2-fold increased risk of prostate cancer was seen for patients whose first melanoma diagnosis was 10 to 15 years before study recruitment.
Skin Cancer News
SKIN CANCER ADVISOR
Skin Cancer News
QOL Up With Pembrolizumab vs Ipilimumab, HDI in Resected Melanoma
Adjuvant pembrolizumab improved quality of life when compared with ipilimumab or high-dose interferon α 2b.
Accredited Hospitals Fail to Disclose Costs of Common Cancer Surgeries
Roughly half of hospitals accredited by the ACS-CoC failed to disclose the cost of 5 common cancer surgeries, researchers found.
Lack of Consensus Regarding Follow-Up After Keratinocyte Carcinoma Treatment
A systematic review of clinical practice guidelines revealed substantial variation in recommendations for follow-up after initial treatment for keratinocyte carcinoma.
Subset of Stage I Melanoma Patients Have Very Low Mortality Rate
Researchers identified a subset of melanoma patients with stage I lesions and negative clinical nodes who had a very low risk of death.
Relatlimab-Nivolumab Combo Deemed Promising in Resectable Melanoma
Relatlimab plus nivolumab yields a high pathologic complete response rate in resectable stage III or oligometastatic stage IV melanoma, a phase 2 study suggests.
Breast Implant-Associated Cancers: What Providers and Patients Need to Know
Patients with breast implants are at risk of developing squamous cell carcinoma and various types of lymphoma in the capsules around the implants.
Socioeconomic Status Predicts Mortality in Melanoma
For patients with melanoma, socioeconomic disparities persist within insured populations, specifically those in nonintegrated health care systems.
USPSTF: Evidence Still Lacking for Routine Skin Cancer Screening
Current evidence is insufficient for assessing the balance of benefits and harms of screening for asymptomatic teens and adults.
COVID-19 Vaccination Should Not Interrupt ICI Therapy, Researchers Say
COVID-19 vaccination is safe for cancer patients receiving immune checkpoint inhibitors and should not interrupt therapy, according to researchers.
Poor Outcomes Seen in Advanced Cancer Patients Treated With Inpatient ICI Therapy
Inpatient treatment with immune checkpoint inhibitors is associated with poor survival outcomes in patients with advanced cancer.
Researchers Identify Optimal Sequence of Treatment for BRAF-Mutant Melanoma
The optimal sequence of treatment for BRAF-mutant melanoma is nivolumab-ipilimumab followed by dabrafenib-trametinib, a study suggests.
American Indians, Alaska Natives Engage in Few Skin Cancer Prevention Behaviors
Researchers at Brigham and Women’s Hospital investigated the skin cancer prevention behaviors of these rarely studied ethnic groups.
SBRT Does Not Improve Efficacy of Nivo-Ipi in Advanced Merkel Cell Carcinoma
SBRT did not improve the efficacy of nivolumab-ipilimumab in patients with advanced Merkel cell carcinoma in a phase 2 study.
Retevmo Approved for RET-Driven Solid Tumors, NSCLC
The approvals were based on data from the LIBRETTO-001 trial.
Data Support Neoadjuvant and Adjuvant Pembrolizumab in Resectable Melanoma
Neoadjuvant plus adjuvant pembrolizumab can prolong event-free survival vs adjuvant pembrolizumab alone in resectable melanoma.
Severity of Sleep Apnea and Related Hypoxia Tied to Cancer
Untreated sleep apnea may be a risk factor for cancer, according to researchers.
Biomarker Analyses May Impact the Speed and Success of Cancer Trials
Researchers compared biomarker and nonbiomarker clinical trials in oncology and identified differences in timelines and the risk of failure.
Tumor-Infiltrating Lymphocytes Outperform Ipilimumab in Advanced Melanoma
Tumor-infiltrating lymphocytes can improve progression-free survival, when compared with ipilimumab, in patients with advanced melanoma, a phase 3 trial suggests.
FDA: Cases of Breast Implant-Related SCC, Various Lymphomas Reported
Following an initial extensive review, the FDA identified less than 20 cases of SCC and less than 30 cases of various lymphomas in the capsule around the breast implant.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Skin Cancer
Loading... 
Loading...